Trastuzumab (Herceptin; Section 7-3) is an antibody that binds to the extracellular domain of the growth factor

Question:

Trastuzumab (Herceptin; Section 7-3) is an antibody that binds to the extracellular domain of the growth factor receptor HER2. Explain why trastuzumab would be an effective treatment for cancer in which cells overexpress HER2.
Fantastic news! We've Found the answer you've been seeking!

Step by Step Answer:

Related Book For  book-img-for-question

Fundamentals of biochemistry Life at the Molecular Level

ISBN: 978-0470547847

4th edition

Authors: Donald Voet, Judith G. Voet, Charlotte W. Pratt

Question Posted: